Delivery Order SPE2DR25D2009-SPE2DR26FJ2W8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,269.88 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed-price delivery order, issued on June 16, 2025, with an ultimate completion date of June 17, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $35,530.01 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed-price delivery order, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a direct procurement of pharmaceutical products to support military and federal healthcare operations. The contract was competitively awarded with no set-aside designation, leveraging...
- The Defense Logistics Agency issued a delivery order valued at $7,166.59 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed-price delivery order, awarded on September 11, 2025, with completion targeted for September 12, 2025, represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. The award was made through open competition with no set-aside designation, and performance will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units at a firm fixed price ceiling value of $1,208.55. This is a non-set-aside, competitively awarded contract with an ultimate completion date of November 6, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $9,986.88 delivery order to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. The contract, which carries a firm fixed price structure with no set-aside designation, was competitively awarded on September 27, 2025, with an ultimate completion date of September 29, 2025. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a $2,569.50 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Mestinon 180 mg Timespan in units of 30, with completion scheduled for September 24, 2025. This firm fixed-price contract represents a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will...
- The Defense Logistics Agency awarded a $10.87K delivery order to AmerisourceBergen Drug Corp for Mestinon 180 mg Timespan tablets (30-count units) under a firm fixed-price contract structure. The award, issued on October 17, 2025, with an ultimate completion date of October 20, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- This delivery order, valued at $2,785.06, awards AmerisourceBergen Drug Corp the supply of Mestinon 180 mg Timespan in quantities of 30 units for the Defense Logistics Agency (DLA). The contract employs firm fixed pricing with no set-aside designation, indicating competitive award, and is scheduled for completion by November 5, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $2,496.72 to AmerisourceBergen Drug Corp for Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed price, non-set-aside contract was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $19,899.87 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg TimeSpan, a neurological medication used in military and veteran healthcare systems. This competitive award, issued on September 25, 2025, with completion targeted for September 26, 2025, represents a firm fixed-price delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ2W8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,095.12 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order was placed on November 6, 2025, with an ultimate completion date of November 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems globally. As a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, AmerisourceBergen maintains an extensive portfolio of brand-name and generic drugs across multiple therapeutic domains, positioning it as a critical vendor in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 11/6/25 |